Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) and Shineco (NASDAQ:SISI – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for Prestige Consumer Healthcare and Shineco, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Prestige Consumer Healthcare | 1 | 3 | 2 | 0 | 2.17 |
| Shineco | 1 | 0 | 0 | 0 | 1.00 |
Prestige Consumer Healthcare presently has a consensus target price of $70.75, indicating a potential upside of 57.51%. Given Prestige Consumer Healthcare’s stronger consensus rating and higher probable upside, research analysts plainly believe Prestige Consumer Healthcare is more favorable than Shineco.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Prestige Consumer Healthcare | 15.57% | 11.39% | 5.66% |
| Shineco | -380.55% | -79.89% | -33.01% |
Insider & Institutional Ownership
100.0% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 4.1% of Shineco shares are held by institutional investors. 1.5% of Prestige Consumer Healthcare shares are held by company insiders. Comparatively, 0.0% of Shineco shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Prestige Consumer Healthcare and Shineco”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Prestige Consumer Healthcare | $1.09 billion | 1.95 | $190.30 million | $3.57 | 12.58 |
| Shineco | $9.60 million | 0.00 | -$22.45 million | ($204.00) | -0.00 |
Prestige Consumer Healthcare has higher revenue and earnings than Shineco. Shineco is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Prestige Consumer Healthcare has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500. Comparatively, Shineco has a beta of -1.76, suggesting that its stock price is 276% less volatile than the S&P 500.
Summary
Prestige Consumer Healthcare beats Shineco on 14 of the 14 factors compared between the two stocks.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
About Shineco
Shineco, Inc., through its subsidiaries, processes and distributes agricultural produce. It also engages in the growing and cultivation of mulberry trees and silkworm cocoons; distribution of fruit business; and processing and distribution of silk and silk fabrics, as well as other by-products. The company was incorporated in 1997 and is headquartered in Beijing, the People's Republic of China.
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
